Michael Berg
General Counsel at TEARLAB CORPORATION
Profile
Michael Berg is currently the Vice President-Regulatory at TearLab Corporation, Inc. since 2006 and the President at Hemocue, Inc. since 2013.
He completed his undergraduate degree at the University of Notre Dame.
Michael Berg active positions
| Companies | Position | Start |
|---|---|---|
| TEARLAB CORPORATION | General Counsel | 2005-12-31 |
| Hemocue, Inc. | President | 2010-05-19 |
Training of Michael Berg
| University of Notre Dame | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
TearLab Corporation, Inc.
 TearLab Corporation, Inc. Medical SpecialtiesHealth Technology TearLab Corporation, Inc. engages in the development and marketing of a tear testing platform. Its primary product, the TearLab Osmolarity System, enables eye care practitioners to test for highly sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. It measures tear film osmolarity for the diagnosis of dry eye disease. The company was founded by Benjamin D. Sullivan in 1996 and is headquartered in Escondido, CA. | Health Technology |
| Hemocue, Inc. |
- Stock Market
- Insiders
- Michael Berg
